Artificial Blood: Global Markets to 2028

Artificial Blood: Global Markets to 2028

Report Scope:

The scope of this study encompasses an investigation of the global market for artificial blood, focusing on various important aspects of the market, such as research and development, clinical trial outcomes, approval status, and the potential commercial demand for artificial blood products. The report includes a discussion of artificial oxygen carrier products. BCC Research analyzes each market segment and provides a forecast for six years. The current report analyzes the market's drivers, challenges, and opportunities. The report also covers market projections for 2028 and the market analysis for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides information on emerging technologies, the impact of COVID-19, product analysis, deals, and investment outlook.

Report Includes:

41 tables

An overview of the global markets for artificial blood

Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028

Highlights of the market potential and characterization of artificial blood market by product, application, and region

Examination of the key drivers and constraints that will shape the market and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and sub-segments

Coverage of recent advances, emerging technologies, and developments of the industry

Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry

Company profiles of major players within the industry, including Hemarina, VirTechBio, and NuvOx Pharma